Ahmad A, Singh R, Nickolich K, Pilewski M, Ngeow C, Frempong-Manso K
Front Immunol. 2025; 16:1529849.
PMID: 39949778
PMC: 11821594.
DOI: 10.3389/fimmu.2025.1529849.
Zubovskaia A, Vazquez J
J Fungi (Basel). 2025; 11(1.
PMID: 39852489
PMC: 11766804.
DOI: 10.3390/jof11010070.
Corzo Leon D, Ahumada-Topete V, Ostrosky-Zeichner L
Access Microbiol. 2024; 6(11).
PMID: 39534303
PMC: 11556431.
DOI: 10.1099/acmi.0.000850.v4.
Konig S, Schroeder J, Heinekamp T, Brakhage A, Loffler B, Engert B
Front Cell Infect Microbiol. 2024; 14:1445428.
PMID: 39473925
PMC: 11518849.
DOI: 10.3389/fcimb.2024.1445428.
Rynda-Apple A, Reyes Servin J, Lenz J, Roemer J, Benson E, Hall M
J Immunol. 2024; 213(8):1202-1211.
PMID: 39212415
PMC: 11816899.
DOI: 10.4049/jimmunol.2200686.
Restoration of Type 17 immune signaling is not sufficient for protection during influenza-associated pulmonary aspergillosis.
Ahmad A, Singh R, Nickolich K, Pilewski M, Ngeow C, Frempong-Manso K
bioRxiv. 2024; .
PMID: 39185245
PMC: 11343153.
DOI: 10.1101/2024.07.01.601559.
[Nosocomial pneumonia].
Ewig S
Anaesthesiologie. 2024; 73(9):630-644.
PMID: 39136734
DOI: 10.1007/s00101-024-01451-z.
Clinical significance of lower respiratory tract culture within 48 h of admission in patients with viral pneumonia: an observational study.
Chen L, Weng H
BMC Pulm Med. 2024; 24(1):372.
PMID: 39085852
PMC: 11293002.
DOI: 10.1186/s12890-024-03162-y.
Optimizing Antifungal Treatment Strategies to Prevent Invasive Pulmonary Aspergillosis Infection-Related Deaths in Intensive Care Unit Patients: The Need for Standardization of Research Definitions.
Bassetti M, Vena A, Bavastro M, Giacobbe D
Mycopathologia. 2024; 189(4):69.
PMID: 39066809
PMC: 11283379.
DOI: 10.1007/s11046-024-00879-6.
Study protocol: A randomized, double-blind, placebo-controlled trial of isavuconazole prophylaxis for the prevention of covid-19-associated pulmonary aspergillosis.
Jenks J, Hoenigl M, Thompson G
Contemp Clin Trials Commun. 2024; 39:101310.
PMID: 38832095
PMC: 11144754.
DOI: 10.1016/j.conctc.2024.101310.
Use of nebulized liposomal amphotericin B and posaconazole as antifungal prophylaxis in patients with severe SARS-CoV2 infection in intensive care unit.
Fumarola B, Signorini L, Lorenzotti S, Lanza P, Saccani B, Van Hauwermeiren E
Infection. 2024; 52(4):1459-1468.
PMID: 38530518
PMC: 11289071.
DOI: 10.1007/s15010-024-02234-9.
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.
Bassetti M, Giacobbe D, Agvald-Ohman C, Akova M, Alastruey-Izquierdo A, Arikan-Akdagli S
Intensive Care Med. 2024; 50(4):502-515.
PMID: 38512399
PMC: 11018656.
DOI: 10.1007/s00134-024-07341-7.
Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.
Zhao J, Zhuo X, Pu D, Fan G, Lu B, Cao B
Eur J Clin Microbiol Infect Dis. 2024; 43(4):683-692.
PMID: 38326545
DOI: 10.1007/s10096-024-04772-4.
Early Detection of Aspergillus Species in Lower Respiratory Tract is Associated with Higher Mortality in Viral Community-Acquired Pneumonia: A Multicenter Prospective Cohort Study in China.
Yin L, Zhang Y, Zheng Y, Luo Q, Zhao L, Ni W
Lung. 2023; 201(4):387-396.
PMID: 37480410
DOI: 10.1007/s00408-023-00638-2.
COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit Patients from Poland.
Skora M, Gajda M, Namysl M, Wordliczek J, Zorska J, Piekielko P
J Fungi (Basel). 2023; 9(6).
PMID: 37367602
PMC: 10303628.
DOI: 10.3390/jof9060666.
Phenotypic Array for Identification and Screening of Antifungals against Isolates from Respiratory Infections in KwaZulu Natal, South Africa.
Naicker S, Mohanlall V, Ngubane S, Mellem J, Mchunu N
J Fungi (Basel). 2023; 9(6).
PMID: 37367552
PMC: 10303164.
DOI: 10.3390/jof9060616.
A Tale of Two Hospitals: Comparing CAPA Infections in Two ICUs During the Spanish Fourth Pandemic Wave.
Sanchez-Castellano M, Marcelo C, Marco J, Figueira-Iglesias J, Garcia-Rodriguez J
Mycopathologia. 2023; 188(4):335-344.
PMID: 37256502
PMC: 10230482.
DOI: 10.1007/s11046-023-00750-0.
Invasive Pulmonary Aspergillosis in Coronavirus Disease 2019 Patients Lights and Shadows in the Current Landscape.
Tsotsolis S, Kotoulas S, Lavrentieva A
Adv Respir Med. 2023; 91(3):185-202.
PMID: 37218799
PMC: 10204408.
DOI: 10.3390/arm91030016.
Managing the Next Wave of Influenza and/or SARS-CoV-2 in the ICU-Practical Recommendations from an Expert Group for CAPA/IAPA Patients.
Peral J, Estella A, Nuvials X, Rodriguez A, Seijas I, Soriano C
J Fungi (Basel). 2023; 9(3).
PMID: 36983480
PMC: 10058160.
DOI: 10.3390/jof9030312.
Immunity to fungi in the lung.
Heung L, Wiesner D, Wang K, Rivera A, Hohl T
Semin Immunol. 2023; 66:101728.
PMID: 36841146
PMC: 10148604.
DOI: 10.1016/j.smim.2023.101728.
